A new study reveals how C210, a curcumin derivative, selectively reactivates Epstein–Barr virus to kill cancer cells without infectious risks, paving the way for safer, targeted cancer therapies.

The images, which are alleged to have been altered ... conditions and to exaggerate the anti-cancer effects of curcumin. ¹ ...